• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肾细胞癌中CD4 +和CD8 +肿瘤浸润淋巴细胞的细胞溶解活性特征

Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.

作者信息

Finke J H, Rayman P, Alexander J, Edinger M, Tubbs R R, Connelly R, Pontes E, Bukowski R

机构信息

Section of Immunology, Cleveland Clinic Foundation, Ohio 44195.

出版信息

Cancer Res. 1990 Apr 15;50(8):2363-70.

PMID:2107973
Abstract

Previously we showed that IL2 expanded tumor-infiltrating lymphocytes (TILs) from renal cell carcinoma mediated non-major histocompatibility complex-restricted cytotoxicity. Phenotypic analysis showed that cultured TILs were composed mostly of T-lymphocytes with varying numbers of CD4+, CD8+, and CD56+ (Leu19+) populations. Here we compared the cytolytic activity of the two predominant TIL subsets, CD3+CD4+ and CD3+CD8+, to that of the CD56+ populations. Using magnetic beads coated with antibodies to either CD4 or CD8, CD3+CD4+, and CD3+CD8+ TILs were isolated in a highly enriched form (greater than 92%) and could be expanded for over 40 days in vitro with 1000 units/ml IL2. In a 4-h 51Cr release assay the CD4+ and CD8+ TILs showed minimal lytic activity, whereas unseparated cells exhibited significant levels of non-major histocompatibility complex-restricted cytotoxicity. The lytic activity seen in the 4-h assay with unseparated TILs appeared to be related to the presence of CD56+ populations. With one exception none of the purified CD4+ or CD8+ TILs expressed any significant levels of CD56, while the unseparated TILs contained varying numbers of CD3+CD56+ and CD3-CD56+ populations. Cell-sorting experiments verified that the CD56+ populations were responsible for most of the lytic activity in 4 h even though CD3+CD56- cells represented the predominant cell type. Although CD3+CD56- TILs were minimally lytic in 4 h, we show here that both CD3+CD4+ and CD3+CD8+ subsets displayed substantial cytotoxicity in long-term assays. In the 18-h 51Cr release assay 5 of 6 CD4+ and 2 of 3 CD8+ TILs were lytic for the autologous tumor. In two cases, restimulation with the autologous tumor induced augmented cytolytic activity of TIL subsets and in one case induced lytic activity in 4 h. The cytotoxic activity of TIL subsets was further examined using a 72-h assay in which TILs were cocultured with a confluent layer of tumor cells. The degree of cytotoxicity was quantitated by measuring the amount of crystal violet dye that was incorporated by tumor cells which remained after the incubation period. CD4+ and CD8+ TILs typically caused greater than a 50% reduction of tumor cells in 3 days and the level of reduction was increased when IL2 was added to the cultures. All the CD4+ and CD8+ subset preparations were cytotoxic in the 3-day assay even though some were not lytic for certain targets in the 18-h 51Cr release assay.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

此前我们发现,白细胞介素2(IL2)可扩增肾细胞癌的肿瘤浸润淋巴细胞(TILs),这些TILs介导非主要组织相容性复合体限制的细胞毒性。表型分析显示,培养的TILs主要由T淋巴细胞组成,包含数量不等的CD4 +、CD8 +和CD56 +(Leu19 +)细胞群。在此,我们比较了两个主要TIL亚群CD3 + CD4 +和CD3 + CD8 +与CD56 +细胞群的细胞溶解活性。使用包被有抗CD4或抗CD8抗体的磁珠,以高度富集的形式(大于92%)分离出CD3 + CD4 +和CD3 + CD8 + TILs,并且在含有1000单位/毫升IL2的培养基中可在体外扩增40多天。在4小时的51Cr释放试验中,CD4 +和CD8 + TILs显示出最小的溶解活性,而未分离的细胞表现出显著水平的非主要组织相容性复合体限制细胞毒性。在未分离的TILs进行的4小时试验中观察到的溶解活性似乎与CD56 +细胞群的存在有关。除一例例外,纯化的CD4 +或CD8 + TILs均未表达任何显著水平的CD56,而未分离的TILs含有数量不等的CD3 + CD56 +和CD3 - CD56 +细胞群。细胞分选实验证实,即使CD3 + CD56 -细胞是主要细胞类型,CD56 +细胞群在4小时内仍负责大部分溶解活性。尽管CD3 + CD56 - TILs在4小时内的溶解活性最小,但我们在此表明,在长期试验中,CD3 + CD4 +和CD3 + CD8 +亚群均表现出显著的细胞毒性。在18小时的51Cr释放试验中,6个CD4 + TILs中的5个和3个CD8 + TILs中的2个对自体肿瘤具有溶解作用。在两个病例中,用自体肿瘤再次刺激可增强TIL亚群的溶解活性,在一个病例中可在4小时内诱导出溶解活性。使用7小时试验进一步检测TIL亚群的细胞毒性活性,即将TILs与肿瘤细胞汇合层共培养。通过测量孵育期后残留肿瘤细胞摄取的结晶紫染料量来定量细胞毒性程度。CD4 +和CD8 + TILs通常在3天内使肿瘤细胞减少超过50%,当向培养物中添加IL2时,减少水平会增加。在3天试验中,所有CD4 +和CD8 +亚群制剂均具有细胞毒性,尽管在18小时的51Cr释放试验中,一些制剂对某些靶标没有溶解作用。(摘要截选至400字)

相似文献

1
Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.人肾细胞癌中CD4 +和CD8 +肿瘤浸润淋巴细胞的细胞溶解活性特征
Cancer Res. 1990 Apr 15;50(8):2363-70.
2
Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.用双特异性单克隆抗体扩增的CD4+和CD8+肿瘤浸润淋巴细胞的特性分析。
J Immunol. 1989 Nov 15;143(10):3404-11.
3
Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.人转移性肾细胞癌中使用或未使用重组白细胞介素-2的肿瘤浸润淋巴细胞的临床结果及特征
Cancer Res. 1991 Aug 15;51(16):4199-205.
4
Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes.浸润人类卵巢肿瘤的淋巴细胞:肿瘤坏死因子α与白细胞介素2在从肿瘤浸润淋巴细胞生成CD8+效应细胞过程中的协同作用。
Cancer Res. 1989 Nov 1;49(21):5979-85.
5
Clonal analysis of lymphocytes from tumor, peripheral blood, and nontumorous kidney in primary renal cell carcinoma.原发性肾细胞癌中肿瘤、外周血及非肿瘤性肾组织淋巴细胞的克隆分析。
Cancer Res. 1990 Sep 1;50(17):5263-8.
6
Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity.白细胞介素2扩增的人肾细胞癌肿瘤浸润淋巴细胞:分离、特性及抗肿瘤活性
Cancer Res. 1988 Jan 1;48(1):206-14.
7
Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.通过从头颈癌患者的血液和淋巴结中进行阳性选择来富集肿瘤反应性CD8 + T淋巴细胞。
Cancer Res. 1991 Aug 1;51(15):3891-9.
8
Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites.浸润卵巢恶性腹水的淋巴细胞导致肿瘤细胞溶解。
Cancer Res. 1991 Aug 15;51(16):4257-65.
9
T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.肾细胞癌中白细胞介素-2激活的肿瘤浸润淋巴细胞的T细胞功能
Reg Immunol. 1992 Jul-Aug;4(4):225-35.
10
Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.活化的人外周血T细胞亚群所表现出的多种细胞溶解机制。
J Immunol. 1992 Jan 1;148(1):55-62.

引用本文的文献

1
Immune Cytolytic Activity and Strategies for Therapeutic Treatment.免疫细胞溶解活性与治疗策略。
Int J Mol Sci. 2024 Mar 23;25(7):3624. doi: 10.3390/ijms25073624.
2
The immunology of renal cell carcinoma.肾细胞癌的免疫学。
Nat Rev Nephrol. 2020 Dec;16(12):721-735. doi: 10.1038/s41581-020-0316-3. Epub 2020 Jul 30.
3
Effects of peritoneal macrophage autophagy on the immune function of sepsis mice.腹膜巨噬细胞自噬对脓毒症小鼠免疫功能的影响
Am J Clin Exp Immunol. 2017 Jun 15;6(4):52-59. eCollection 2017.
4
Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls.德国肾细胞癌患者与健康对照者之间HLA-I类和II类等位基因频率的差异。
Cancer Immunol Immunother. 2017 May;66(5):565-571. doi: 10.1007/s00262-017-1957-3. Epub 2017 Feb 9.
5
Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer.微卫星不稳定型结直肠癌中高CD4阳性T细胞浸润与HLA II类调节基因突变的关联
Cancer Immunol Immunother. 2015 Mar;64(3):357-66. doi: 10.1007/s00262-014-1638-4. Epub 2014 Dec 2.
6
Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape.髓源性抑制细胞依附于生理性 STAT3 对 STAT5 的依赖性造血编程,建立了多种肿瘤介导的免疫逃避机制。
Immunol Invest. 2012;41(6-7):680-710. doi: 10.3109/08820139.2012.703745.
7
Cytotoxic chemotherapy and CD4+ effector T cells: an emerging alliance for durable antitumor effects.细胞毒性化疗与CD4+效应T细胞:实现持久抗肿瘤效应的新兴联合
Clin Dev Immunol. 2012;2012:890178. doi: 10.1155/2012/890178. Epub 2012 Feb 6.
8
EMAP-II-dependent lymphocyte killing is associated with hypoxia in colorectal cancer.EMAP-II 依赖性淋巴细胞杀伤与结直肠癌中的缺氧有关。
Br J Cancer. 2006 Sep 18;95(6):735-43. doi: 10.1038/sj.bjc.6603299. Epub 2006 Aug 22.
9
Modulation of MUC1 mucin as an escape mechanism of breast cancer cells from autologous cytotoxic T-lymphocytes.MUC1粘蛋白的调节作为乳腺癌细胞逃避自体细胞毒性T淋巴细胞的一种机制。
Br J Cancer. 2001 May 4;84(9):1258-64. doi: 10.1054/bjoc.2000.1744.
10
Prognostic value of the immunomonitoring of patients with renal cell carcinoma under therapy with IL-2/IFN-alpha-2 in combination with 5-FU.白细胞介素-2/α-干扰素-2联合5-氟尿嘧啶治疗肾细胞癌患者时免疫监测的预后价值
Urol Res. 1996;24(5):297-303. doi: 10.1007/BF00304780.